Xeris Pharmaceuticals



Xeris Pharmaceuticals is a specialty company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology.

Allison Wey
Senior Vice President of Investor Relations and Corporate Communications
Barry Deutsch
Chief Financial Officer
Beth P. Hecht
General Counsel & Secretary
John Shannon
Chief Operating Officer
Ken Johnson
SVP, Clinical Development, Regulatory, Quality Assurance & Medical Affairs
Kevin McCulloch
Senior Vice President, Global Operations & Business Development
Steven Prestrelski
Chief Scientific Officer & Co-Founder

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.